Waters Posts 3 Percent Revenue Decline for Q3, but Beats Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Waters today reported a 3 percent decline in its third quarter revenues year over year, but the firm said that it sees a stabilization in its end markets after a difficult first half of the year.

The Milford, Mass.-based firm reported total revenues of $374 million for the three-month period ended Oct. 3, down from $386.3 million for Q3 2008. The firm said that 1 percent of that decline was due to adverse foreign currency translation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.